Home โ€บ Stocks โ€บ PGHH

Procter & Gamble Hygiene and Health Care Ltd share price

PGHH ยท BSE
โ‚น6,894.25โ–ฒ 38.80 (0.57%)
Open
โ‚น6,801.00
Prev close
โ‚น6,855.45
Day high
โ‚น6,954.75
Day low
โ‚น6,801.00
52-wk high
โ€”
52-wk low
โ€”
See Procter & Gamble Hygiene and Health Care Ltd live on Traddx Interactive charts, deep fundamentals, peer comparison & your own watchlist โ€” one of 4,800+ NSE & BSE stocks. Free to explore, no card needed.
Open live โ†’
๐Ÿ”” Get a free alert when Procter & Gamble Hygiene and Health Care Ltd moves Set a price alert, save PGHH to your watchlist, and unlock the full AI deep dive. Free account โ€” 10 seconds with Google, no password.
Create free account โ†’

Procter & Gamble Hygiene and Health Care Ltd (PGHH) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the FMCG theme. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ€” which star investors hold it and who is buying it on today's bulk/block deals tape.

See PGHH live in the app โ†’

Procter & Gamble Hygiene and Health Care Limited value chain โ€” customers, suppliers & competitors

Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded fast-moving consumer goods, primarily focusing on feminine hygiene and healthcare products in India. It sits as a downstream brand owner, buying raw materials and packaging inputs to sell finished consumer goods through retail networks.

๐Ÿ›’ Customers โ€” who buys from Procter & Gamble Hygiene and Health Care Limited

โ›“๏ธ Suppliers โ€” raw materials & inputs

  • Packaging and Chemical Suppliers โ€” Corrugated boxes, plastic films, and active chemical ingredients

โš”๏ธ Competitors โ€” other sellers

๐Ÿ”€ Other suppliers to its customers

๐Ÿค Peers that share its suppliers

This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.